Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

Compared with other epithelial ovarian carcinoma subtypes, ovarian clear cell carcinoma (OCCC) has been recognized to show chemoresistance. Therefore, new treatment modalities are required for patients with OCCC that is refractory to chemotherapy. The carcinoembryonic antigen glypican-3 (GPC3) is ex...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncoimmunology
Autori principali: Suzuki, Shiro, Sakata, Jun, Utsumi, Fumi, Sekiya, Ryuichiro, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139642/
https://ncbi.nlm.nih.gov/pubmed/27999758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238542
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi